Melatonin modulates mitochondrial function and inhibits atherosclerosis progression through NRF2 activation and OPA1 inhibition

This study is the first to elucidate that MLT synergistically ameliorates mitochondrial dysfunction through dual mechanisms-activating the NRF2 antioxidant pathway and suppressing OPA1-mediated mitochondrial fusion-providing novel therapeutic targets for AS.